MiMedx – Financial Treason & Crime

Carl Surran, 26 November 2019

Former MiMedx (OTC:MDXG -1%) executives Parker Petit and William Taylor are indicted by the Department of Justice on charges of accounting fraud during 2015-16 that overstated the company’s revenues and misled investors.
The SEC separately filed a civil suit against MiMedx, Petit, Taylor and former CFO Michael Senken, accusing them of conducting a “pervasive” accounting fraud during 2013-17. Continue reading “Article: MiMedx former CEO and COO indicted for accounting fraud”

07/01/201903/03/2021

Article: Marc Cohodes’ Last Stand – Part One: Encountering the Fraud

Article - Media, Publications

Marc Cohodes’ Last Stand – Part One: Encountering the Fraud

Real Vision, 01 July 2019

This is the first part of the groundbreaking January 2019 interview between Real Vision co-founder Grant Williams (NYSE:WMB) and legendary short seller Marc Cohodes. In this clip from the long conversation, the two introduce Cohodes’ battle to expose the truth about pharmaceutical giant MiMedx. This is excerpted from a video published on Real Vision on February 1, 2019 entitled “Fraud, Intimidation and Truth: Marc Cohodes’ Last Stand.” Continue reading “Article: Marc Cohodes’ Last Stand – Part One: Encountering the Fraud”

05/07/201903/02/2021

Article: Prescience Point Nominates Slate of Highly-Qualified Director Candidates for Election to MiMedx Board

Article - Media, Publications

Prescience Point Nominates Slate of Highly-Qualified Director Candidates for Election to MiMedx Board

PRNewswire, 07 May 2019

Prescience Point Capital Management, LLC, a private investment management firm, together with certain investment partnerships under its management (collectively, “Prescience Point”), today announced that it has nominated a slate of four world-class candidates for election to the MiMedx Group, Inc. (“MiMedx” or the “Company”) (Ticker: MDXG) Board of Directors (the “Board”) at the Company’s upcoming Annual Meeting of Shareholders (the “Annual Meeting”), scheduled to be held on June 17, 2019. Prescience Point, together with its director nominees, owns approximately 9.98% of the common stock of MiMedx. Continue reading “Article: Prescience Point Nominates Slate of Highly-Qualified Director Candidates for Election to MiMedx Board”